Exchange Traded Concepts’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Exchange Traded Concepts’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,909	Closed	-$282K	–	1317
2024 Q1	$282K	Buy	17,909 +7,462	+71%	+$115K	0.01%	831
2023 Q4	$169K	Buy	10,447 +2,649	+34%	+$33.8K	﹤0.01%	814
2023 Q3	$99.2K	Sell	7,798 -2,005	-20%	-$27.7K	﹤0.01%	901
2023 Q2	$138K	Buy	+9,803	New	+$140K	﹤0.01%	866

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Exchange Traded Concepts's DCPH Position: Q2 2024 in Review

Exchange Traded Concepts sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 17,909 shares — an estimated $282K sold.

Exchange Traded Concepts first reported a position in DCPH in Q2 2023 and held it in 4 quarters. The position peaked at $282K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Exchange Traded Concepts reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Exchange Traded Concepts sold 17,909 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $282K.
Exchange Traded Concepts first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
Exchange Traded Concepts's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $282K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Exchange Traded Concepts's 13F filing for Q2 2024, filed 13 Aug 2024.